Filing Details
- Accession Number:
- 0001593968-20-001950
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-01 18:34:36
- Reporting Period:
- 2020-09-29
- Accepted Time:
- 2020-10-01 18:34:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
887247 | Adamis Pharmaceuticals Corp | ADMP | Pharmaceutical Preparations (2834) | 820429727 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1461736 | O Robert Hopkins | C/O Adamis Pharmaceuticals Corporation 11682 El Camino Real, Ste 300 San Diego CA 92130 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-09-29 | 20,000 | $0.80 | 274,781 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were for the sole purpose of satisfying or paying income or withholding tax obligations of the undersigned.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a price $0.80 in each transaction.